Devereaux P J, Goldman Lee, Yusuf Salim, Gilbert Ken, Leslie Kate, Guyatt Gordon H
Department of Medicine, McMaster University, Hamilton, Ont.
CMAJ. 2005 Sep 27;173(7):779-88. doi: 10.1503/cmaj.050316.
This is the second of 2 articles evaluating cardiac events in patients undergoing noncardiac surgery. Unrecognized myocardial infarctions (MIs) are common, and up to 50% of perioperative MIs may go unrecognized if physicians rely only on clinical signs or symptoms. In this article, we summarize the evidence regarding monitoring strategies for perioperative MI in patients undergoing noncardiac surgery. Perioperative troponin measurements and 12-lead electrocardiograms can detect clinically silent MIs and provide independent prognostic information. Currently, there are no standard diagnostic criteria for perioperative MIs in patients undergoing noncardiac surgery. We propose diagnostic criteria that reflect the unique features of perioperative MIs. Finally, we review the evidence for perioperative prophylactic cardiac interventions. There is encouraging evidence that some perioperative interventions (e.g., beta-blockers, alpha2-adrenergic agonists, statins) may prevent major cardiac ischemic events, but firm conclusions await the results of large definitive trials. The best evidence does not support a management strategy of preoperative coronary revascularization before noncardiac surgery.
本文是评估非心脏手术患者心脏事件的两篇文章中的第二篇。未被识别的心肌梗死(MI)很常见,如果医生仅依靠临床体征或症状,高达50%的围手术期心肌梗死可能未被识别。在本文中,我们总结了关于非心脏手术患者围手术期心肌梗死监测策略的证据。围手术期肌钙蛋白测量和12导联心电图可检测出临床无症状的心肌梗死,并提供独立的预后信息。目前,对于接受非心脏手术的患者,围手术期心肌梗死尚无标准诊断标准。我们提出了反映围手术期心肌梗死独特特征的诊断标准。最后,我们回顾了围手术期预防性心脏干预的证据。有令人鼓舞的证据表明,一些围手术期干预措施(如β受体阻滞剂、α2肾上腺素能激动剂、他汀类药物)可能预防重大心脏缺血事件,但确切结论有待大型确定性试验的结果。最佳证据不支持在非心脏手术前进行术前冠状动脉血运重建的管理策略。